Education
About Us
Working with TipRanks
Follow Us
Jonathan Couchman Insider Profile
11 Followers
Jonathan Couchman, Director at Pernix Therapeutics, holds 326.40K shares in Pernix Therapeutics (Ticker: PTXTQ), holds 9.44M shares in Enzon Pharmaceuticals (Ticker: ENZN). Most recently, Jonathan Couchman ― shares of Pernix Therapeutics on ― for an estimated value of ―.
Profitable Transactions
5 out of 6 Profitable Transactions
Average Return
+39.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Jonathan Couchman's holdings
Insider Roles
Ten Percent Owner
Roles that Jonathan Couchman holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jan 09, 2019 - Jan 09, 2020
Return:+75.00%
The most profitable trade made by Jonathan Couchman
Jonathan Couchman's Trading History
Pernix Therapeutics
―
―
―
$9.14K
Enzon Pharmaceuticals
Aug 26, 2020
Ten Percent Owner
Informative Sell
14.13K
$1.72M
List of latest transactions for each holding click on a transaction to see Jonathan Couchman's performance on stock
You May Also Like
Jonathan Couchman insider profile FAQ
What is the percentage of profitable transactions made by Jonathan Couchman?
The percentage of profitable transactions made by Jonathan Couchman is 83%.
What is the average return per transaction made by Jonathan Couchman?
The average return per transaction made by Jonathan Couchman is 39.80%.
What stocks does Jonathan Couchman hold?
Jonathan Couchman holds: PTXTQ, ENZN stocks.
What was Jonathan Couchman’s latest transaction?
Jonathan Couchman latest transaction was an Uninformative Buy of ―.
What was Jonathan Couchman's most profitable transaction?
Jonathan Couchman’s most profitable transaction was an Informative Buy of ENZN stock on January 9, 2019. The return on the trade was 75.00%.
What is Jonathan Couchman's role in Pernix Therapeutics?
Jonathan Couchman's role in Pernix Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.